Coronavirus drugs, Sanofi, Novartis and more—FiercePharmaAsia by Angus Liu Friday, January 31, 2020 China is repurposing existing drugs for coronavirus. South Korea arrested a Sanofi exec for a vaccine case. Novartis outlined ambitious China plan.
Sanofi exec in Korea arrested in vaccine bribery probe: report by Eric Sagonowsky Tuesday, January 28, 2020 A Sanofi exec in Korea was among seven people arrested as officials look into bid-rigging in vaccines, MLex reports.
Samsung execs face jail time over evidence destruction by Angus Liu Monday, December 9, 2019 Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.
Astellas, China's NRDL, Hanmi and more—FiercePharmaAsia by Angus Liu Friday, December 6, 2019 Astellas buys gene therapy player Audentes for $3 billion. Keytruda and Opdivo fail to win coverage in China. Hanmi inks I-O deal with Rapt.
CVS pulls Zantac, generics as recall spreads around the globe by Eric Palmer Monday, September 30, 2019 The Zantac recall is quickly turning into a landslide as CVS pulled Zantac and its generics as did countries from Korea to Bangladesh.
Korean drugmaker buys large Vietnamese plant by Eric Palmer Wednesday, September 4, 2019 South Korea’s JW Pharmaceutical has started targeting emerging markets with a deal for a plant in Vietnam.
South Korean CDMO consolidates with HQ in California by Eric Palmer Tuesday, September 3, 2019 South Korea's SK Holdings is rolling three API operations into a new unit, SK Pharmteco, and has put its headquarters in Sacramento, California.
Takeda union accuses drugmaker of favoring Shire employees by Angus Liu Friday, August 2, 2019 Original Takeda employees alleged faced unfair changes in their roles and got different incentive plans during the integration.
Samsung Bioepis, Celltrion, GenScript and more—FiercePharmaAsia by Angus Liu Friday, July 26, 2019 Samsung Bioepis wins FDA nod for a Humira biosim; Celltrion forms Chinese biosim joint venture; GenScript debuts a clinical biologics plant.
Global first nods, Celgene-BeiGene and more—FiercePharmaAsia by Angus Liu Friday, June 21, 2019 Roche, Daiichi and AZ nab global first nods from Japan; Celgene hands back PD-1 to BeiGene; China offers incentive to generic makers.
